Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Thursday's Intraday Session

Author: Benzinga Insights | March 20, 2025 12:06pm

Gainers

  • Impact BioMedical (AMEX:IBO) stock increased by 226.4% to $1.73 during Thursday's regular session. The market value of their outstanding shares is at $19.9 million.
  • Plus Therapeutics (NASDAQ:PSTV) shares moved upwards by 205.28% to $1.56. The market value of their outstanding shares is at $9.1 million.
  • OptiNose (NASDAQ:OPTN) stock moved upwards by 54.63% to $9.28. The company's market cap stands at $93.2 million.
  • Windtree Therapeutics (NASDAQ:WINT) stock rose 31.36% to $2.22. The company's market cap stands at $1.6 million.
  • CervoMed (NASDAQ:CRVO) stock moved upwards by 27.84% to $11.98. The company's market cap stands at $98.8 million. As per the news, the Q4 earnings report came out 3 days ago.
  • ARS Pharmaceuticals (NASDAQ:SPRY) stock moved upwards by 26.43% to $14.73. The company's market cap stands at $1.4 billion. The company's, Q4 earnings came out today.

Losers

  • Elevation Oncology (NASDAQ:ELEV) stock fell 38.8% to $0.29 during Thursday's regular session. The company's market cap stands at $17.3 million.
  • Adaptimmune Therapeutics (NASDAQ:ADAP) stock decreased by 28.51% to $0.32. The market value of their outstanding shares is at $82.1 million. As per the press release, Q4 earnings came out today.
  • Akebia Therapeutics (NASDAQ:AKBA) shares declined by 28.35% to $2.04. The company's market cap stands at $480.7 million.
  • Venus Concept (NASDAQ:VERO) stock fell 20.28% to $2.59. The company's market cap stands at $1.7 million.
  • Rockwell Medical (NASDAQ:RMTI) shares fell 18.76% to $1.43. The market value of their outstanding shares is at $46.2 million. As per the news, the Q4 earnings report came out today.
  • Biodexa Pharmaceuticals (NASDAQ:BDRX) shares decreased by 17.1% to $1.94. The market value of their outstanding shares is at $1.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ADAP AKBA BDRX CRVO ELEV IBO OPTN PSTV RMTI SPRY VERO WINT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist